Genome & Co. Bets On Rosy Microbiome Outlook

Manufacturing Is Biggest Challenge, CEO Says

 
• By Jung Won Shin
  
microbiome
Genome & Co. Acquires List Labs For $27m • Source: Alamy

More from South Korea

More from Focus On Asia